Chemed (NYSE:CHE) Reaches New 52-Week Low After Earnings Miss

Chemed Corporation (NYSE:CHE)’s share price reached a new 52-week low on Thursday following a dissappointing earnings announcement. The company traded as low as $395.00 and last traded at $401.9530, with a volume of 175330 shares trading hands. The stock had previously closed at $466.60.

The company reported $6.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The business had revenue of $639.34 million for the quarter, compared to analysts’ expectations of $659.09 million. The firm’s revenue was down .1% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.83 earnings per share. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, February 23rd. Chemed’s dividend payout ratio is presently 12.69%.

Analyst Ratings Changes

A number of analysts recently issued reports on CHE shares. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Royal Bank Of Canada dropped their target price on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research report on Monday, November 10th. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Finally, Jefferies Financial Group downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $555.50.

Institutional Investors Weigh In On Chemed

Institutional investors and hedge funds have recently bought and sold shares of the business. Commonwealth Equity Services LLC boosted its stake in Chemed by 3.1% in the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock valued at $314,000 after acquiring an additional 22 shares during the period. WCM Investment Management LLC lifted its holdings in shares of Chemed by 3.8% in the 3rd quarter. WCM Investment Management LLC now owns 661 shares of the company’s stock worth $299,000 after purchasing an additional 24 shares during the last quarter. Eukles Asset Management boosted its position in Chemed by 0.4% during the 3rd quarter. Eukles Asset Management now owns 6,031 shares of the company’s stock valued at $2,700,000 after purchasing an additional 24 shares during the period. Cim LLC grew its stake in Chemed by 1.1% during the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after buying an additional 24 shares during the last quarter. Finally, Atria Investments Inc increased its position in Chemed by 0.6% in the second quarter. Atria Investments Inc now owns 4,259 shares of the company’s stock worth $2,074,000 after buying an additional 25 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Price Performance

The stock has a market capitalization of $5.53 billion, a price-to-earnings ratio of 20.65, a price-to-earnings-growth ratio of 2.28 and a beta of 0.44. The company has a 50-day simple moving average of $447.24 and a two-hundred day simple moving average of $444.38.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.